Related Experiment Video

Updated: Jul 5, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

Issues with reducing the rotavirus-associated mortality by vaccination in developing countries

Mohammadreza Naghipour1, Toyoko Nakagomi, Osamu Nakagomi

  • 1Division of Molecular Epidemiology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan. naghi@nagasaki-u.ac.jp

Vaccine
|May 13, 2008
PubMed

Insights

Rotavirus vaccine can save many young lives in Asia and Africa, but health system inequities hinder access. Comprehensive strategies are needed to overcome these barriers and increase immunization coverage to prevent child deaths.

Area of Science:

  • Global Health
  • Pediatrics
  • Vaccinology

Background:

  • Rotavirus infections cause a significant number of deaths in children under five, particularly in low-resource settings.
  • In 2004, over 65% of global rotavirus deaths occurred in 11 Asian and African countries, resulting in 345,000 fatalities.
  • Existing rotavirus vaccines are effective, but their impact is limited by health delivery system inequities.

Purpose of the Study:

  • To analyze the potential impact of rotavirus vaccination in high-burden countries.
  • To identify the primary obstacles to achieving widespread rotavirus vaccine coverage.
  • To emphasize the need for strategies addressing health system inequities.

Main Methods:

  • Modeling the potential reduction in rotavirus deaths by applying current vaccine coverage rates.
  • Estimating remaining mortality even with an 80% vaccination coverage.
  • Identifying health system inequity as a critical barrier.

Main Results:

  • Applying current vaccine coverage to rotavirus vaccines could avert a maximum of 202,550 deaths.
  • Even with 80% coverage, an estimated 96,841 children would still die from rotavirus diarrhea in the studied countries.
  • Health delivery system inequity is the major impediment to rotavirus vaccine goals.

Conclusions:

  • Rotavirus vaccination holds significant life-saving potential for young children in Asia and Africa.
  • Addressing and resolving health system inequities is crucial for maximizing vaccine impact.
  • Further research and comprehensive strategies are essential to increase immunization coverage and reduce rotavirus-related child mortality.

More Related Videos

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...